Your browser doesn't support javascript.
loading
Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
Fu, Yi; Wei, Xindong; Han, Qiuqin; Le, Jiamei; Ma, Yujie; Lin, Xinjie; Xu, Yuhui; Liu, Ning; Wang, Xuan; Kong, Xiaoni; Gu, Jinyang; Tong, Ying; Wu, Hailong.
Afiliación
  • Fu Y; Affiliated Zhoupu Hospital, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, China.
  • Wei X; Shanghai Key Laboratory of Molecular Imaging, Collaborative Innovation Center for Biomedicines, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, China.
  • Han Q; School of Medical Instruments, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, China.
  • Le J; Nanjing University of Traditional Chinese Medicine, Nanjing, 210000, China.
  • Ma Y; Affiliated Zhoupu Hospital, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, China.
  • Lin X; Shanghai Key Laboratory of Molecular Imaging, Collaborative Innovation Center for Biomedicines, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, China.
  • Xu Y; Affiliated Zhoupu Hospital, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, China.
  • Liu N; Shanghai Key Laboratory of Molecular Imaging, Collaborative Innovation Center for Biomedicines, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, China.
  • Wang X; Shanghai Key Laboratory of Molecular Imaging, Collaborative Innovation Center for Biomedicines, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, China.
  • Kong X; Shanghai Key Laboratory of Molecular Imaging, Collaborative Innovation Center for Biomedicines, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, China.
  • Gu J; Graduate School of Art and Sciences, Columbia University, New York, NY, 10027, USA.
  • Tong Y; Department of Clinical Oncology, Taian City Central Hospital, Taian, 271000, Shandong, China.
  • Wu H; Department of General Surgery, Nanjing General Hospital of Nanjing Military Command, Nanjing, 210000, China.
BMC Cancer ; 21(1): 1165, 2021 Oct 30.
Article en En | MEDLINE | ID: mdl-34717566
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Perfilación de la Expresión Génica / ARN Largo no Codificante / Neoplasias Hepáticas / Recurrencia Local de Neoplasia Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Perfilación de la Expresión Génica / ARN Largo no Codificante / Neoplasias Hepáticas / Recurrencia Local de Neoplasia Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido